| |
 |
Details: |
 |
|
|
Develops and manufactures slow-release adhesive patches for skin or oral cavity. Includes product range, news archive and contacts for investors in Miami, Florida. (Nasdaq: NOVN)
|
| URL: |
http://www.noven.com/
|
| Title: |
Welcome to Noven Pharmaceuticals, Inc. (Nasdaq:NOVN) |
| Image: |
 |
| Description: |
Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Delivery Systems - Noven Pharmaceuticals, Inc.. Develops and manufactures slow-release adhesive patches for skin or oral cavity. |
| Similar: |
|
|
|
Related Sites |
|
PSA Chemicals and Pharmaceuticals Pvt. Ltd. (Popularity:  ): Contract manufacturer of formulations from Vashi, Navi Mumbai, India. [requires Flash]
Emisphere Technologies, Inc. (Popularity: ): Researches and develops proprietary technology for oral administration of proteins. Based in Tarrytown, New York. (Nasdaq: EMIS).
Cima Labs Inc. (Popularity: ): Develops and markets fast dissolving tablets. Overview of Products and company in Eden Prairie, Minnesota. (Nasdaq: CIMA).
Aradigm Corp. (Popularity: ): Develops hand-held pulmonary drug delivery systems designed to enhance effectiveness of drugs. Based in Hayward, California, USA. (Nasdaq: ARDM)
Glycologic (Popularity: ): Develops carbohydrate based formulations for rapid, delayed or sustained release and taste masking of pharmaceuticals and nutrients.
Alkermes, Inc. (Popularity: ): Develops sustained-release injectables and inhalers for delivering drugs such as insulin. Includes product details, technology, investor news and contacts in ...
Corium (Popularity: ): Develops, engineers and manufactures products and devices that utilize the skin and mucosa as a means of transport.
MedPharm (Popularity: ): Specialists in drug delivery and developing therapeutic products for human use, based in Kings College London.
Medspray (Popularity: ): MedSpray develops devices and the manufacturing technology for the monodisperse aerosol and spray devices. The devices generate aerosols with pre-set ...
Concomp-Partner (Popularity: ): The ConComp database (B Braun) supplies information concerning the stability of drugs in various combinations of active ingredients, diluents, container-materials. ...
Sonus Pharmaceuticals, Inc. (Popularity: ): Researches and develops proprietary emulsions for lipophilic drugs, including formulations for cancer treatment. Outlines phase II studies, presentation and profile ...
|
|
Popular Sites |
|
Intra Pump (Popularity: ): Developer of personal medical pumps for infusion and injection therapy.
Formulation Information Site (Popularity: ): Drug delivery, controlled release information site. Keywords, drug delivery, pulmonary delivery, needle free, microspheres, nasal delivery, oral drug delivery, transdermal, ...
Noven Pharmaceuticals, Inc. (Popularity: ): Develops and manufactures slow-release adhesive patches for skin or oral cavity. Includes product range, news archive and contacts for investors ...
Mika Pharma GmbH (Popularity: ): Develops and produces dermal and transdermal application systems for pharmaceuticals on the basis of sprayable liposomes and preliposomal solutions. Includes ...
Watson Pharmaceuticals Inc. (Popularity: ): Develop, manufacture and market brand and generic pharmaceutical products utilizing various drug delivery technologies. Includes product data, career opportunities, and ...
|
|
Related Press |
|
Great Lakes Pharmaceuticals, Inc., Announces $2.4 Million Equity Financing (Popularity: ): Great Lakes Pharmaceuticals, Inc. announced today the completion of Series A $2.4 million equity financing led by Ohio investment funds ...
Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease (Popularity: ): Iodine has been used as an antimicrobial for the last century. Much has been written about molecular iodine yet many ...
Watson' Launches Generic Kadian(R) (Popularity: ): PARSIPPANY, N.J., Nov. 10, 2011 -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that it has received approval from the ...
Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis (Popularity: ): Cerimon Pharmaceuticals, Inc., announced today it has initiated a Phase II proof-of-concept study of Simulect(R) (basiliximab) for the treatment of ...
DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease (Popularity: ): Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs, announced today that after completing its review of safety ...
|
|
Related Articles |
|
|
|
|
